Abg-wtt Global Life Science Capital Partners GP LTD
ABG-WTT Global Life Science Capital Partners GP Ltd is a Hong Kong-based private equity investment firm affiliated with Ally Bridge Group, specializing in the life sciences sector. The firm acts as the general partner for ABG-WTT Global Life Science Capital Partners, L.P., investing in growth-stage life sciences companies globally, with a particular focus on healthcare and biotech innovation. The firm was founded in the early 2020s and serves institutional investors and high net worth individuals seeking exposure to transformative healthcare technologies.
Investment Strategy
ABG-WTT Global Life Science Capital Partners GP Ltd pursues an active investment strategy focused on identifying high-growth life science companies, primarily in the healthcare and biotechnology sectors. The firm seeks to invest in companies with disruptive platforms and products, targeting significant value accretion through strategic guidance and access to global networks. Its portfolio includes direct investments in companies developing cutting-edge diagnostics, therapeutics, and medical devices. The firm favors late-stage private placements and select public market opportunities, prioritizing scalability and potential for global impact.
Top Holdings
Equity Positions (2)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CBLL | CERIBELL INC | 76.17% | $20.4M | 1,088,101 | $25.88 | $18.73 | -$522.3K |
R RPID | RAPID MICRO BIOSYSTEMS INC | 23.83% | $6.4M | 1,848,296 | $4.97 | $3.45 | +$1.5M |